The Board of Directors of Georgia CORE, the Center for Oncology Research and Education, announces the election of Andrew W. Pippas, MD, as Chairman of its Board of Directors. Dr. Pippas has served on the Board since 2009.
Dr. Roland Matthews of Morehouse School of Medicine, Vice Chair of the Georgia CORE Board and Chair of the Nominating Committee noted, â€œDr. Pippas is ideally suited to assume the role of Chair. He represents a leading institution, the John B. Amos Cancer Center of Columbus Regional Health. He has served as a member of the Georgia CORE Board and Executive Committee and as an investigator on Georgia CORE clinical trials. We are delighted to have such an accomplished physician to continue the tradition of community oncology leadership of Georgia CORE.â€
Dr. Pippas is Chief Medical Officer and Director of Clinical Research with the John B. Amos Cancer Center, a comprehensive, multi-disciplinary program accredited by the Commission on Cancer of the American College of Surgeons. The John B. Amos Cancer Center is also the only treatment center with this designation in the 14-county service area of Columbus, Georgia and has an active portfolio of 40 clinical trials.
Born and raised in Salt Lake City, Utah, Dr. Pippas received his B.A. in Physics from Northwestern University. He earned his Doctor of Medicine from the University of Utahâ€™s School of Medicine in Salt Lake City, and completed his residency in internal medicine and a fellowship in medical oncology/hematology at the Duke University Medical Center in Durham, North Carolina. He is board-certified in Medical Oncology and is a recipient of the National Institutes of Health’s Physician Scientist Award. He is also an active member of the American Society of Clinical Oncology and the American Society of Hematology
Dr. Pippas noted, â€œIt is an honor to serve as the Chair of Georgia CORE â€“ the main mechanism for enhancing oncology collaboration and clinical trials accrual in the state.â€ Dr. Pippas succeeds Dr. Thomas E. Seay who served as chair from 2009 until his death in December.